Cell Signaling Technology

CaMKIV Antibody

#4032 · $317

60

Evidence Score · Well-Established

Used by 97 independent labs across 100 papers. How we score this →

100

Citing papers

12.2k

Combined citations

Supplier page Find this product

Research areas

Cancer-related Molecular Pathways15 Advanced Breast Cancer Therapies9 Melanoma and MAPK Pathways8 PI3K/AKT/mTOR signaling in cancer6 Immune Cell Function and Interaction5 Immune cells in cancer5 Cytokine Signaling Pathways and Interactions5 Autophagy in Disease and Therapy5

Papers citing this product

1

Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL

The Journal of Cell Biology·2010·1.3k cit.·DOI

2

Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

Nature Communications·2015·1.1k cit.·DOI

3

A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells

Blood·2007·496 cit.·DOI

4

Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence

Oncogene·2016·430 cit.·DOI

5

BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications

PLoS ONE·2011·309 cit.·DOI

6

Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer

Endocrine Related Cancer·2011·299 cit.·DOI

7

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

Blood·2012·297 cit.·DOI

8

Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer

Nucleic Acids Research·2020·228 cit.·DOI

9

The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition

Journal of Molecular Signaling·2010·221 cit.·DOI

10

Dual role of α-defensin-1 in anti–HIV-1 innate immunity

Journal of Clinical Investigation·2005·220 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.